Antimicrobial agent in PurThread high performance fabrics keeps products free from bioburden and odor
Durham, NC – November 14, 2013 – PurThread Technologies, Inc. and Eastman Kodak Company are collaborating to bring Kodak’s antimicrobial agent to the high performance and medical textile markets.
PurThread has obtained a globally exclusive agreement to embed Kodak’s antimicrobial agent into textile materials. PurThread’s 2013 TechAmerica Award-winning process embeds Kodak’s antimicrobial agent into synthetic fibers, before the fiber is spun into yarn and woven into fabric, ensuring that the antimicrobial effects of the fabric are uniform and constant throughout the life of the product. This proprietary antimicrobial technology is derived from Kodak’s longtime expertise related to the production of photosensitive materials for use in the production of photographic products.
Currently, PurThread’s product line includes healthcare textiles, such as medical scrubs, lab coats, privacy curtains and linens, as well as fitness apparel, like polo shirts and base layers. The company is also partnering with leaders in the textile industry to manufacture its products and bring this next-generation technology to discerning consumer brands.
“We are extremely pleased with the efficacy of Kodak’s antimicrobial agent and their stewardship in the development of our textile technology,” said Lisa Grimes, President & CEO of PurThread Technologies. “With Kodak’s superior technology, our products have delivered consistently high marks for effectiveness in protecting fabrics from odor-causing organisms. We look forward to continuing research into how our textile products can play a part in comprehensive infection control strategies.”
“The antimicrobial technology sector is an exciting new venture for Kodak,” said Tom McHugh, General Manager, Materials Technology & Business Development for Kodak’s Digital Printing & Enterprise segment. “Because of PurThread’s unique manufacturing process and expertise in the textile industry, we are delighted to be working with them to bring to market products using our propriety materials and technology. We look forward to building on this relationship with PurThread.”
A double-blind randomized controlled trial published in December found that PurThread privacy curtains resisted contamination 7 times longer than control curtains – which were also 8 times more likely to be contaminated with the superbug VRE (Vancomycin-Resistant Enterococci), compared to PurThread’s curtains. This study, conducted by the University of Iowa, is the only randomized controlled trial to examine the role of antimicrobial privacy curtains.
PurThread Technologies Inc., an emerging leader in antimicrobial textile technology and scientific research, is dedicated to developing continuously active soft surfaces that show a measurable difference in reducing bioburden in clinical environments. PurThread products range from healthcare textiles, such as privacy curtains, lab coats, scrubs, blankets, and sheets, to an array of freshness products for other markets such as the military, emergency first responders and performance athletic wear. PurThread products incorporate an EPA-registered antimicrobial that protects the fabric from the effects of microbial contamination and reduces odor-causing bacteria, mold, mildew and fungus. The EPA has not yet reviewed any public health claims for PurThread products. PurThread fibers and fabrics are 100% Made in the USA. More information can be found at www.purthread.com.